S
Market Data
$1.21+$0.02 (+1.68%)
SPRO · Last trade
Prev Close
$1.19
Range (30d)
$1.15 – $1.27
Recent Filings
- 8-K210.3 KBSpero Therapeutics, Inc.Aug 12, 4:09 PM ET·0001193125-26-346855
- 10-Q14.6 MBSpero Therapeutics, Inc.Aug 12, 4:03 PM ET·0001193125-26-346795
- 8-K3.5 MBSpero Therapeutics, Inc.Jul 14, 6:30 AM ET·0001193125-26-302473
- 8-K175.0 KBSpero Therapeutics, Inc.Jun 25, 5:08 PM ET·0001193125-26-283033
- 8-K183.4 KBSpero Therapeutics, Inc.Jun 22, 4:05 PM ET·0001193125-26-277506
- 10-Q8.6 MBSpero Therapeutics, Inc.May 13, 4:05 PM ET·0001193125-26-221591
- 8-K194.5 KBSpero Therapeutics, Inc.May 13, 4:02 PM ET·0001193125-26-221567
- 8-K215.2 KBSpero Therapeutics, Inc.Mar 26, 4:10 PM ET·0001193125-26-126244
- 10-K13.7 MBSpero Therapeutics, Inc.Mar 26, 4:05 PM ET·0001193125-26-126192
- 8-K138.0 KBSpero Therapeutics, Inc.Jan 30, 5:01 PM ET·0001193125-26-032004
Insiders
10- Alphabet Inc.10% Owner
- Aquilo Capital, L.P.10% Owner
- Aquilo Capital Management, LLC10% Owner
- Atlas Venture Associates IX, LLC10% Owner
- Atlas Venture Associates IX, L.P.10% Owner
- Atlas Venture Fund IX, L.P.10% Owner
- Breum CasperDirector
- Deshpande MilindDirector
- DiPalma Stephen J.See Remarks
- FORMELA JEAN FRANCOISDirector
Tickers
Addresses
business
675 MASSACHUSETTS AVENUE 14TH FLOOR
CAMBRIDGE, MA, 02139
mailing
675 MASSACHUSETTS AVENUE 14TH FLOOR
CAMBRIDGE, MA, 02139
Former Names
- Spero Therapeutics, LLC2017-03-21